Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Intensity of care for cancer patients treated mainly at home during the month before their death: An observational study.

Tuppin P, Tanguy-Melac A, Lesuffleur T, Janah A, Gastaldi-Ménager C, Fagot-Campagna A.

Presse Med. 2019 Nov 13. pii: S0755-4982(19)30450-6. doi: 10.1016/j.lpm.2019.09.044. [Epub ahead of print]

PMID:
31734050
2.

Health care utilization by men with prostate cancer during the year before their death: A 2015 population-based study.

Tanguy-Melac A, Lesuffleur T, Fagot-Campagna A, Gastaldi-Ménager C, Rébillard X, Tuppin P.

Prog Urol. 2019 Nov 7. pii: S1166-7087(19)30540-8. doi: 10.1016/j.purol.2019.09.006. [Epub ahead of print]

PMID:
31708329
3.

Long-term adverse events after sleeve gastrectomy or gastric bypass: a 7-year nationwide, observational, population-based, cohort study.

Thereaux J, Lesuffleur T, Czernichow S, Basdevant A, Msika S, Nocca D, Millat B, Fagot-Campagna A.

Lancet Diabetes Endocrinol. 2019 Oct;7(10):786-795. doi: 10.1016/S2213-8587(19)30191-3. Epub 2019 Aug 2.

PMID:
31383618
4.

Multicentre cohort study of antihypertensive and lipid-lowering therapy cessation after bariatric surgery.

Thereaux J, Lesuffleur T, Czernichow S, Basdevant A, Msika S, Nocca D, Millat B, Fagot-Campagna A.

Br J Surg. 2019 Feb;106(3):286-295. doi: 10.1002/bjs.10999. Epub 2018 Oct 16.

PMID:
30325504
5.

Role of working conditions in the explanation of occupational inequalities in work injury: findings from the national French SUMER survey.

Niedhammer I, Lesuffleur T, Labarthe G, Chastang JF.

BMC Public Health. 2018 Mar 12;18(1):344. doi: 10.1186/s12889-018-5254-7.

6.

Association Between Bariatric Surgery and Rates of Continuation, Discontinuation, or Initiation of Antidiabetes Treatment 6 Years Later.

Thereaux J, Lesuffleur T, Czernichow S, Basdevant A, Msika S, Nocca D, Millat B, Fagot-Campagna A.

JAMA Surg. 2018 Jun 1;153(6):526-533. doi: 10.1001/jamasurg.2017.6163.

7.

Long-term follow-up after bariatric surgery in a national cohort.

Thereaux J, Lesuffleur T, Païta M, Czernichow S, Basdevant A, Msika S, Millat B, Fagot-Campagna A.

Br J Surg. 2017 Sep;104(10):1362-1371. doi: 10.1002/bjs.10557. Epub 2017 Jun 28.

PMID:
28657109
8.

Working conditions in the explanation of occupational inequalities in sickness absence in the French SUMER study.

Niedhammer I, Lesuffleur T, Memmi S, Chastang JF.

Eur J Public Health. 2017 Dec 1;27(6):1061-1068. doi: 10.1093/eurpub/ckx052.

PMID:
28549123
9.

To What Extent Does Posthospital Discharge Chemoprophylaxis Prevent Venous Thromboembolism After Bariatric Surgery?: Results From a Nationwide Cohort of More Than 110,000 Patients.

Thereaux J, Lesuffleur T, Czernichow S, Basdevant A, Msika S, Nocca D, Millat B, Fagot-Campagna A.

Ann Surg. 2018 Apr;267(4):727-733. doi: 10.1097/SLA.0000000000002285.

PMID:
28475558
10.

Do sleeve gastrectomy and gastric bypass influence treatment with proton pump inhibitors 4 years after surgery? A nationwide cohort.

Thereaux J, Lesuffleur T, Czernichow S, Basdevant A, Msika S, Nocca D, Millat B, Fagot-Campagna A.

Surg Obes Relat Dis. 2017 Jun;13(6):951-959. doi: 10.1016/j.soard.2016.12.013. Epub 2016 Dec 23.

PMID:
28223087
11.

Contribution of working conditions to occupational inequalities in depressive symptoms: results from the national French SUMER survey.

Niedhammer I, Lesuffleur T, Coutrot T, Chastang JF.

Int Arch Occup Environ Health. 2016 Aug;89(6):1025-37. doi: 10.1007/s00420-016-1142-6. Epub 2016 May 19.

PMID:
27197816
12.

[Psychosocial work factors and self-reported health in the French national SUMER survey].

Lesuffleur T, Chastang JF, Cavet M, Niedhammer I.

Sante Publique. 2015 Mar-Apr;27(2):177-86. French.

PMID:
26414030
13.

Psychosocial factors at work and occupational injury: results from the French national SUMER survey.

Lesuffleur T, Chastang JF, Sandret N, Niedhammer I.

J Occup Environ Med. 2015 Mar;57(3):262-9. doi: 10.1097/JOM.0000000000000345.

PMID:
25742532
14.

Classic and emergent psychosocial work factors and mental health.

Niedhammer I, Lesuffleur T, Algava E, Chastang JF.

Occup Med (Lond). 2015 Mar;65(2):126-34. doi: 10.1093/occmed/kqu173. Epub 2014 Dec 22.

PMID:
25534947
15.

Psychosocial factors at work and sickness absence: results from the French national SUMER survey.

Lesuffleur T, Chastang JF, Sandret N, Niedhammer I.

Am J Ind Med. 2014 Jun;57(6):695-708. doi: 10.1002/ajim.22317. Epub 2014 Mar 17.

PMID:
24639009
16.

Overexpression of microRNAs-155 and 21 targeting mismatch repair proteins in inflammatory bowel diseases.

Svrcek M, El-Murr N, Wanherdrick K, Dumont S, Beaugerie L, Cosnes J, Colombel JF, Tiret E, Fléjou JF, Lesuffleur T, Duval A.

Carcinogenesis. 2013 Apr;34(4):828-34. doi: 10.1093/carcin/bgs408. Epub 2013 Jan 3.

PMID:
23288924
17.

MiRNA genes constitute new targets for microsatellite instability in colorectal cancer.

El-Murr N, Abidi Z, Wanherdrick K, Svrcek M, Gaub MP, Fléjou JF, Hamelin R, Duval A, Lesuffleur T.

PLoS One. 2012;7(2):e31862. doi: 10.1371/journal.pone.0031862. Epub 2012 Feb 14.

18.

Autocrine induction of invasive and metastatic phenotypes by the MIF-CXCR4 axis in drug-resistant human colon cancer cells.

Dessein AF, Stechly L, Jonckheere N, Dumont P, Monté D, Leteurtre E, Truant S, Pruvot FR, Figeac M, Hebbar M, Lecellier CH, Lesuffleur T, Dessein R, Grard G, Dejonghe MJ, de Launoit Y, Furuichi Y, Prévost G, Porchet N, Gespach C, Huet G.

Cancer Res. 2010 Jun 1;70(11):4644-54. doi: 10.1158/0008-5472.CAN-09-3828. Epub 2010 May 11.

19.

NADPH oxidase 1 modulates WNT and NOTCH1 signaling to control the fate of proliferative progenitor cells in the colon.

Coant N, Ben Mkaddem S, Pedruzzi E, Guichard C, Tréton X, Ducroc R, Freund JN, Cazals-Hatem D, Bouhnik Y, Woerther PL, Skurnik D, Grodet A, Fay M, Biard D, Lesuffleur T, Deffert C, Moreau R, Groyer A, Krause KH, Daniel F, Ogier-Denis E.

Mol Cell Biol. 2010 Jun;30(11):2636-50. doi: 10.1128/MCB.01194-09. Epub 2010 Mar 29.

20.

REG4 acts as a mitogenic, motility and pro-invasive factor for colon cancer cells.

Rafa L, Dessein AF, Devisme L, Buob D, Truant S, Porchet N, Huet G, Buisine MP, Lesuffleur T.

Int J Oncol. 2010 Mar;36(3):689-98.

PMID:
20126989
21.

Nod2 regulates the host response towards microflora by modulating T cell function and epithelial permeability in mouse Peyer's patches.

Barreau F, Madre C, Meinzer U, Berrebi D, Dussaillant M, Merlin F, Eckmann L, Karin M, Sterkers G, Bonacorsi S, Lesuffleur T, Hugot JP.

Gut. 2010 Feb;59(2):207-17. doi: 10.1136/gut.2008.171546. Epub 2009 Oct 15.

PMID:
19837677
22.

Nod2 mediates susceptibility to Yersinia pseudotuberculosis in mice.

Meinzer U, Esmiol-Welterlin S, Barreau F, Berrebi D, Dussaillant M, Bonacorsi S, Chareyre F, Niwa-Kawakita M, Alberti C, Sterkers G, Villard C, Lesuffleur T, Peuchmaur M, Karin M, Eckmann L, Giovannini M, Ollendorff V, Wolf-Watz H, Hugot JP.

PLoS One. 2008 Jul 23;3(7):e2769. doi: 10.1371/journal.pone.0002769.

23.

Frequent mutations of the CA simple sequence repeat in intron 1 of EGFR in mismatch repair-deficient colorectal cancers.

Buisine MP, Wacrenier A, Mariette C, Leteurtre E, Escande F, Aissi S, Ketele A, Leclercq A, Porchet N, Lesuffleur T.

World J Gastroenterol. 2008 Feb 21;14(7):1053-9.

24.

CARD15/NOD2 is required for Peyer's patches homeostasis in mice.

Barreau F, Meinzer U, Chareyre F, Berrebi D, Niwa-Kawakita M, Dussaillant M, Foligne B, Ollendorff V, Heyman M, Bonacorsi S, Lesuffleur T, Sterkers G, Giovannini M, Hugot JP.

PLoS One. 2007 Jun 13;2(6):e523.

25.

Genetic analysis of peroxisome proliferator-activated receptor gamma1 splice variants in human colorectal cell lines.

Fiatte C, Huin C, Bertin I, Lesuffleur T, Pluvinet A, Touche N, Plénat F, Dauça M, Domenjoud L, Schohn H.

Int J Oncol. 2006 Dec;29(6):1601-10.

PMID:
17089002
26.

Differential mucin expression in colon carcinoma HT-29 clones with variable resistance to 5-fluorouracil and methotrexate.

Leteurtre E, Gouyer V, Rousseau K, Moreau O, Barbat A, Swallow D, Huet G, Lesuffleur T.

Biol Cell. 2004 Mar;96(2):145-51.

PMID:
15050369
27.

Reg IV, a new member of the regenerating gene family, is overexpressed in colorectal carcinomas.

Violette S, Festor E, Pandrea-Vasile I, Mitchell V, Adida C, Dussaulx E, Lacorte JM, Chambaz J, Lacasa M, Lesuffleur T.

Int J Cancer. 2003 Jan 10;103(2):185-93.

28.

Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-X(L) in addition to Bax and p53 status.

Violette S, Poulain L, Dussaulx E, Pepin D, Faussat AM, Chambaz J, Lacorte JM, Staedel C, Lesuffleur T.

Int J Cancer. 2002 Apr 1;98(4):498-504.

30.

Specific secretion of gel-forming mucins and TFF peptides in HT-29 cells of mucin-secreting phenotype.

Gouyer V, Wiede A, Buisine MP, Dekeyser S, Moreau O, Lesuffleur T, Hoffmann W, Huet G.

Biochim Biophys Acta. 2001 May 28;1539(1-2):71-84.

31.

Differential effect of GalNAcalpha-O-bn on intracellular trafficking in enterocytic HT-29 and Caco-2 cells: correlation with the glycosyltransferase expression pattern.

Gouyer V, Leteurtre E, Delmotte P, Steelant WF, Krzewinski-Recchi MA, Zanetta JP, Lesuffleur T, Trugnan G, Delannoy P, Huet G.

J Cell Sci. 2001 Apr;114(Pt 8):1455-71.

32.

Synergistic efficacy of 3n-butyrate and 5-fluorouracil in human colorectal cancer xenografts via modulation of DNA synthesis.

Bras-Gonçalves RA, Pocard M, Formento JL, Poirson-Bichat F, De Pinieux G, Pandrea I, Arvelo F, Ronco G, Villa P, Coquelle A, Milano G, Lesuffleur T, Dutrillaux B, Poupon MF.

Gastroenterology. 2001 Mar;120(4):874-88.

PMID:
11231942
33.

Postmitotic differentiation of colon carcinoma caco-2 cells does not prevent reentry in the cell cycle and tumorigenicity.

Pandrea IV, Carrière V, Barbat A, Cambier D, Dussaulx E, Lesuffleur T, Rousset M, Zweibaum A.

Exp Mol Pathol. 2000 Aug;69(1):37-45.

PMID:
10891291
34.

Inhibition of mucin glycosylation.

Huet G, Delannoy P, Lesuffleur T, Hennebicq S, Degand P.

Methods Mol Biol. 2000;125:261-71. Review. No abstract available.

PMID:
10820766
35.

Permanent exposure of mucin-secreting HT-29 cells to benzyl-N-acetyl-alpha-D-galactosaminide induces abnormal O-glycosylation of mucins and inhibits constitutive and stimulated MUC5AC secretion.

Hennebicq-Reig S, Lesuffleur T, Capon C, De Bolos C, Kim I, Moreau O, Richet C, Hémon B, Recchi MA, Maës E, Aubert JP, Real FX, Zweibaum A, Delannoy P, Degand P, Huet G.

Biochem J. 1998 Aug 15;334 ( Pt 1):283-95.

36.

GalNAc-alpha-O-benzyl inhibits NeuAcalpha2-3 glycosylation and blocks the intracellular transport of apical glycoproteins and mucus in differentiated HT-29 cells.

Huet G, Hennebicq-Reig S, de Bolos C, Ulloa F, Lesuffleur T, Barbat A, Carrière V, Kim I, Real FX, Delannoy P, Zweibaum A.

J Cell Biol. 1998 Jun 15;141(6):1311-22.

37.

Resistance to high concentrations of methotrexate and 5-fluorouracil of differentiated HT-29 colon-cancer cells is restricted to cells of enterocytic phenotype.

Lesuffleur T, Violette S, Vasile-Pandrea I, Dussaulx E, Barbat A, Muleris M, Zweibaum A.

Int J Cancer. 1998 May 4;76(3):383-92.

38.
39.

Alteration in mucin gene expression and biological properties of HT29 colon cancer cell subpopulations.

Kitamura H, Cho M, Lee BH, Gum JR, Siddiki BB, Ho SB, Toribara NW, Lesuffleur T, Zweibaum A, Kitamura Y, Yonezawa S, Kim YS.

Eur J Cancer. 1996 Sep;32A(10):1788-96.

PMID:
8983291
40.

Characterization of a mucin cDNA clone isolated from HT-29 mucus-secreting cells. The 3' end of MUC5AC?

Lesuffleur T, Roche F, Hill AS, Lacasa M, Fox M, Swallow DM, Zweibaum A, Real FX.

J Biol Chem. 1995 Jun 9;270(23):13665-73.

41.

Modifications of the anti-oxidant metabolism during proliferation and differentiation of colon tumor cell lines.

Bravard A, Beaumatin J, Dussaulx E, Lesuffleur T, Zweibaum A, Luccioni C.

Int J Cancer. 1994 Dec 15;59(6):843-7.

PMID:
7989127
42.

Expression of cytochrome P-450 3A in HT29-MTX cells and Caco-2 clone TC7.

Carrière V, Lesuffleur T, Barbat A, Rousset M, Dussaulx E, Costet P, de Waziers I, Beaune P, Zweibaum A.

FEBS Lett. 1994 Dec 5;355(3):247-50. Erratum in: FEBS Lett 1995 Mar 27;362(1):99.

43.

Mucins in normal and neoplastic human gastrointestinal tissues.

Lesuffleur T, Zweibaum A, Real FX.

Crit Rev Oncol Hematol. 1994 Dec;17(3):153-80. Review. No abstract available.

PMID:
7865137
44.

[Expression of laminin is correlated to the differentiation of human colonic cancer cells].

De Arcangelis A, Simo P, Lesuffleur T, Kedinger M, Simon-Assmann P.

Gastroenterol Clin Biol. 1994;18(6-7):630-7. French.

PMID:
7875421
45.

Differential expression of the human mucin genes MUC1 to MUC5 in relation to growth and differentiation of different mucus-secreting HT-29 cell subpopulations.

Lesuffleur T, Porchet N, Aubert JP, Swallow D, Gum JR, Kim YS, Real FX, Zweibaum A.

J Cell Sci. 1993 Nov;106 ( Pt 3):771-83.

46.

cis-Golgi resident proteins and O-glycans are abnormally compartmentalized in the RER of colon cancer cells.

Egea G, Francí C, Gambús G, Lesuffleur T, Zweibaum A, Real FX.

J Cell Sci. 1993 Jul;105 ( Pt 3):819-30.

47.

Expression and characterization of mucins associated with the resistance to methotrexate of human colonic adenocarcinoma cell line HT29.

Dahiya R, Lesuffleur T, Kwak KS, Byrd JC, Barbat A, Zweibaum A, Kim YS.

Cancer Res. 1992 Sep 1;52(17):4655-62.

48.

Dihydrofolate reductase gene amplification-associated shift of differentiation in methotrexate-adapted HT-29 cells.

Lesuffleur T, Barbat A, Luccioni C, Beaumatin J, Clair M, Kornowski A, Dussaulx E, Dutrillaux B, Zweibaum A.

J Cell Biol. 1991 Dec;115(5):1409-18.

49.

Increased growth adaptability to 5-fluorouracil and methotrexate of HT-29 sub-populations selected for their commitment to differentiation.

Lesuffleur T, Kornowski A, Augeron C, Dussaulx E, Barbat A, Laboisse C, Zweibaum A.

Int J Cancer. 1991 Nov 11;49(5):731-7.

PMID:
1937959
50.

Adaptation to 5-fluorouracil of the heterogeneous human colon tumor cell line HT-29 results in the selection of cells committed to differentiation.

Lesuffleur T, Kornowski A, Luccioni C, Muleris M, Barbat A, Beaumatin J, Dussaulx E, Dutrillaux B, Zweibaum A.

Int J Cancer. 1991 Nov 11;49(5):721-30.

PMID:
1937958

Supplemental Content

Loading ...
Support Center